Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...
The Center for Clinical and Translational Science (CCTS) strives to build synergistic collaborations across the CTSA consortium, elevating translational science to a new heights. From March 5-7th, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback